{"id":"W2603632799","doi":"10.1200/jco.2012.30.15_suppl.8018","title":"Phase II, randomized, double blind, placebo-controlled study comparing siltuximab plus bortezomib versus bortezomib alone in pts with relapsed/refractory multiple myeloma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Bortezomib; Internal medicine; Clinical endpoint; Multiple myeloma; Refractory (planetary science); Gastroenterology; Dexamethasone; Placebo; Randomized controlled trial; Urology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002357372,0.00251682,0.00434083,0.0005974689,0.0005808524,0.001314398,0.001426639,0.002175831,0.01037301],"category_scores_gemma":[0.00209319,0.001164245,0.001538127,0.0005876732,0.001775338,0.001232738,0.0004816981,0.00358406,0.001992892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008920047,"about_ca_system_score_gemma":0.001858016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009512827,"about_ca_topic_score_gemma":0.001691554,"domain_scores_codex":[0.9992234,0.0004123021,0.00005250122,0.0001455226,0.00005343536,0.0001127675],"domain_scores_gemma":[0.998643,0.0003665008,0.0003389055,0.00008663997,0.00009165722,0.000473306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9850882,0.007184405,0.0002045052,0.0003586787,0.0003191027,0.00002011302,0.00002150501,0.0001328897,0.002125637,0.00004271559,0.0004009039,0.004101409],"study_design_scores_gemma":[0.9278226,0.07075741,0.0004316503,0.00001429236,0.0001685865,0.00001396808,0.000009698883,0.0002154622,0.0002352506,0.00006057739,0.0002648722,0.000005707408],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9690252,0.004909253,0.001684862,0.001310223,0.001608205,0.01597746,0.002067416,0.0003766175,0.003040615],"genre_scores_gemma":[0.9659023,0.00335582,0.003197944,0.002476978,0.001225794,0.01649592,0.001520329,0.00006290606,0.005762071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01037301,"threshold_uncertainty_score":0.03470111,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1848560529788988,"score_gpt":0.4819584062365803,"score_spread":0.2971023532576815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}